Kam Man Hui (Kam M Hui)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Cancers

The EMBO journal

Cancer gene therapy

Experimental biology and medicine (Maywood, N.J.)

Institute of Molecular and Cell Biology

Northwestern University - Chicago (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Molecular and Cell Biology

Singapore

PI

National Institute for Medical Research

United Kingdom

Scientific Staff Member

Royal London Hospital

United Kingdom

Postdoctoral Fellow

Education History

Northwestern University - Chicago

United States

PHD

Washington State University

United States

MSC

Washington State University

United States

BSC

Publications

Min Hee Yang, Mina Lee, Amudha Deivasigamani, Duc Dat Le, Chakrabhavi Dhananjaya Mohan, Kam Man Hui, Gautam Sethi, Yeong Shik Kim
Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model. Cancers 15 (19) (2023)
Min Hee Yang, Chakrabhavi Dhananjaya Mohan, Amudha Deivasigamani, Arunachalam Chinnathambi, Sulaiman Ali Alharbi, Kanchugarakoppal S Rangappa, Sang Hoon Jung, Hyejin Ko, Kam Man Hui, Gautam Sethi, Yeong Shik Kim
Procaine Abrogates the Epithelial-Mesenchymal Transition Process through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma. Cancers 14 (20) (2022)
Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao, Heng Dong, Yu Wang, Hongping Xia, Amudha Deivasigamani, Minjie Wu, Karthik Sekar, Hengjun Gao, Mengqing Sun, Yuqin Niu, Qian Li, Lin Tao, Zhen Yan, Menglan Wang, Shasha Chen, Shujuan Zhao, Dajing Chen, Lina Li, Fan Yang, Haojin Gao, Baodong Chen, Ling Su, Liang Xu, Ye Chen, Veerabrahma Pratap Seshachalam, Gongxing Chen, Jayantha Gunaratne, Wanjin Hong, Junping Shi, Gongying Chen, David S Grierson, Benoit Chabot, Tian Xie, Kam Man Hui, Jianxiang Chen
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma. Nature communications 13 (1) (2022)
Ser Yue Loo, Nicholas Li-Xun Syn, Angele Pei-Fern Koh, Janet Cheng-Fei Teng, Amudha Deivasigamani, Tuan-Zea Tan, Aye Aye Thike, Shireen Vali, Shweta Kapoor, Xiaoyuan Wang, Jiong-Wei Wang, Puay Hoon Tan, George W Yip, Gautam Sethi, Ruby Yun-Ju Huang, Kam Man Hui, Lingzhi Wang, Boon Cher Goh, Alan Prem Kumar
Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers. Cell death discovery 7 (1) (2021)
Hongjin Chen, Fubing Wu, Haojun Xu, Guanqun Wei, Min Ding, Fanggui Xu, Amudha Deivasigamani, Guoren Zhou, Kam Man Hui, Hongping Xia
Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways. Cancer gene therapy (2021)
Yiting Qiao, Yunxin Pei, Miao Luo, Muthukumar Rajasekaran, Kam Man Hui, Jianxiang Chen
Cytokinesis regulators as potential diagnostic and therapeutic biomarkers for human hepatocellular carcinoma. Experimental biology and medicine (Maywood, N.J.) 246 (12) (2021)
Jianxiang Chen, Muthukumar Rajasekaran, Hongping Xia, Shik Nie Kong, Amudha Deivasigamani, Karthik Sekar, Hengjun Gao, Hannah Lf Swa, Jayantha Gunaratne, London Lucien Ooi, Tian Xie, Wanjin Hong, Kam Man Hui
CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling. The EMBO journal 37 (20) (2018)

Kam Man Hui.css-eqlu8i{font-size:small;padding-left:4px;} (Kam M Hui)

Publication Activity (10 Years)

Top Topics

Top Venues

Kam Man Hui (Kam M Hui)